Your browser doesn't support javascript.
loading
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma.
Huwyler, Fabrizio; Kunz, Rebekka; Bacher, Ulrike; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Banz, Yara; Pabst, Thomas.
Afiliação
  • Huwyler F; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Kunz R; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Hoffmann M; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Banz Y; Institute of Pathology, Inselspital, University of Bern, 3008 Bern, Switzerland.
  • Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
Cancers (Basel) ; 15(7)2023 Mar 31.
Article em En | MEDLINE | ID: mdl-37046753
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article